Grateful to our patients and colleagues for all we have learned from them while working on our review of the immune checkpoint inhibitor journey. We keep learning to take better care of our patients and improve treatment outcomes.
doi.org/10.36401/JIPO-…
innovationsjournals-jipo.kglmeridian.com The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact Readers can claim CME credit for reading this article via InnoScholar. For complete details, visit innoscholar.com/course/jipo-cme-immune-checkpoint-inhibitors-journey/ ABSTRACT Immune checkpoint... doi.org/10.36401/JIPO-…